Boxuan Zhou
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer.
Journal: Frontiers in immunology
Published: April 24, 2026
IFI44 Orchestrates an IL-10-Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signature.
Journal: Breast cancer (Dove Medical Press)
Published: November 16, 2025
The impact of m6A modified cargo conveyed by exosomes on the tumor microenvironment.
Journal: Discover oncology
Published: November 12, 2025
Multifunctional NIR-Triggered Nanozyme-Based Microneedles for Synergistic Eradication of MRSA and Enhanced Wound Healing.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 11, 2025
Corrigendum to "Chitosan-based hydrogels in cancer therapy: Drug and gene delivery, stimuli-responsive carriers, phototherapy and immunotherapy" [International Journal of Biological Macromolecules, Volume 282, Part 2, December 2024, 137047].
Journal: International journal of biological macromolecules
Published: April 26, 2025
Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer.
Journal: Cancer letters
Published: February 05, 2025
Liver-breast communication of adipocyte-oriented exosomes drives primary mammary cancer progression.
Liver-breast communication of adipocyte-oriented exosomes drives primary mammary cancer progression.
Journal: Cell metabolism
Published: November 14, 2024
Bioinformatics analysis to identify environmental endocrine chemicals that target endometriosis genes.
Journal: Ecotoxicology and environmental safety
Published: October 14, 2024
Chitosan-based hydrogels in cancer therapy: Drug and gene delivery, stimuli-responsive carriers, phototherapy and immunotherapy.
Journal: International journal of biological macromolecules
Published: September 30, 2024
Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma.
Journal: International journal of nanomedicine
Published: September 26, 2024
Correction: CREBZF mRNA nanoparticles suppress breast cancer progression through a positive feedback loop boosted by circPAPD4.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 04, 2023
CREBZF mRNA nanoparticles suppress breast cancer progression through a positive feedback loop boosted by circPAPD4.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 07, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026